SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
---|---|---|---|---|---|
SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
SYSMHC00053_JY100am | 3 | Human | HLA-A02_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00053_JY100fm | 3 | Human | HLA-A02_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00053_JY10fm | 3 | Human | HLA-A02_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00053_JY1fm | 3 | Human | HLA-A02_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00053_PBMC001 | 2 | Human | HLA-A02_01,HLA-A24_02,HLA-B35_01,HLA-B55_01 | ||
SYSMHC00053_PBMC002 | 2 | Human | HLA-A01_01,HLA-A23_01,HLA-B44_02,HLA-B44_05 | ||
SYSMHC00053_PBMC003 | 2 | Human | HLA-A11_01,HLA-A32_01,HLA-B18_01,HLA-B44_02 | ||
SYSMHC00053_PBMC004 | 3 | Human | HLA-A01_01,HLA-A02_01,HLA-B07_02 | ||
SYSMHC00053_PBMC005 | 3 | Human | HLA-A03_01,HLA-A07_02,HLA-B35_01 | ||
SYSMHC00053_PBMC006 | 3 | Human | HLA-A01_01,HLA-A03_01,HLA-B08_01,HLA-B44_02 | ||
SYSMHC00053_PBMC007 | 3 | Human | HLA-A02_01,HLA-A31_01,HLA-B18_01,HLA-B40_01 | ||
SYSMHC00053_PBMC008 | 5 | Human | HLA-A11_01,HLA-B44_02,HLA-B55_01 | ||
SYSMHC00053_PBMC009 | 3 | Human | HLA-A24_02,HLA-A32_01,HLA-B07_02,HLA-B14_02 |
ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
SYSMHC00053 | SYSMHC00053_PBMC008 | PBMC008_msms21.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | class I | HLA-A11_01,HLA-B44_02,HLA-B55_01 | 31589052 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | nanoflow high-performance LC | no | DDA | CID | 1 | |||||
SYSMHC00053 | SYSMHC00053_PBMC008 | PBMC008_msms22.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | class I | HLA-A11_01,HLA-B44_02,HLA-B55_01 | 31589052 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | nanoflow high-performance LC | no | DDA | CID | 2 | |||||
SYSMHC00053 | SYSMHC00053_PBMC008 | PBMC008_msms23.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | class I | HLA-A11_01,HLA-B44_02,HLA-B55_01 | 31589052 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | nanoflow high-performance LC | no | DDA | CID | 3 | |||||
SYSMHC00053 | SYSMHC00053_PBMC008 | PBMC008_msms24.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | class I | HLA-A11_01,HLA-B44_02,HLA-B55_01 | 31589052 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | nanoflow high-performance LC | no | DDA | CID | 4 | |||||
SYSMHC00053 | SYSMHC00053_PBMC008 | PBMC008_msms25.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | class I | HLA-A11_01,HLA-B44_02,HLA-B55_01 | 31589052 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | nanoflow high-performance LC | no | DDA | CID | 5 |